ISSUER DOSSIER · CIK 0002084032

Salspera, Inc. (TKVA)

Issuer profile3 captured filing nodes

Business context

Core business: healthcare product development and commercialization. Products or assets: drug candidates, therapies or medical-device assets. Commercial model: research, regulatory progression and commercialization.

First captured2026-02-23

Latest filingS-1/A · 2026-03-20

Registration path0 initial filings · 3 amendments

What to watch next

Compare the next amendment against the current filing, then monitor for EFFECT or 424B. Material offering terms can change between amendments.

Latest captured filing: S-1/A · 2026-03-20 · 132 days ago.

Official filing timeline

2026-03-20S-1/A · official filing
Salspera, Inc. (TKVA)
2026-03-10S-1/A · official filing
Salspera, Inc. (TKVA)
2026-02-23S-1/A · official filing
Salspera, Inc. (TKVA)

Open latest official filing →